Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer

NCT00411229 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1035

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Sanofi

Collaborators

[object Object]